Abstract
Early and efficient diagnosis of diseases is essential for a correct choice of treatment, in order to avoid complications and increase the survival rate. The development of new technologies for detection of biomarkers appears as an alternative to the currently available methods, and one of the most interesting approaches today is the use of CRISPR/Cas systems for detection of nucleic acid…